News from the healthcare data industry
June 12, 2024 08:00 AM Eastern Daylight Time SAN FRANCISCO–(BUSINESS WIRE)–Today, Komodo Health launches Komodo Patient Insurance™ (KPI), a first-of-its-kind data offering featuring in-depth insights into the insurance status of...
Real World Health Raises £1.37m To Help NHS Maximise Value of Data to Improve Patient Care LONDON, 12th June 2024 – Real World Health has closed a £1.37 million funding round to help...
CAMBRIDGE, Mass., June 10, 2024 /PRNewswire/ — ConcertAI, the leader in oncology predictive and generative AI SaaS Solutions and Real-World Data for healthcare and life sciences, today announced that Timothy (Tim) Albury has joined...
HealthVerity to offer AnalyticsIQ race and ethnicity data linked to over 2 million NPIs We are now able to provide insights into the race and ethnicity of approximately 85% of...
CAMBRIDGE, Mass., June 2, 2024 /PRNewswire/ — ConcertAI, the leading oncology real-world evidence data and AI SaaS technology company, today announced a collaboration with NVIDIA to advance a broad set of translational...
The Company is Also Forging Strategic Partnerships With Pharmaceutical Companies and Vertically Integrated Healthcare Companies to Drive Evidence Adoption in Oncology and other Specialty areas May 23, 2024 09:24 AM...
Solutions enable both research and clinical teams with precision oncology, accelerating clinical trials, increasing patient access, and driving improved patient outcomes CAMBRIDGE, Mass., May 31, 2024 /PRNewswire/ — ConcertAI, a leader in oncology...
May 22, 2024 09:00 AM Eastern Daylight Time NEW YORK–(BUSINESS WIRE)–Today, COTA announced an extension of its research collaboration with ​​the U.S. Food and Drug Administration’s (FDA) Oncology Center of...
WEST CHESTER, Pa., May 22, 2024 (GLOBE NEWSWIRE) — Syapse, a leading real-world oncology data company announced the launch of its latest real-world data offering: Syapse Cohorts: Essentials. This new offering expands...
The European Medicines Agency (EMA) is seeking feedback on non-interventional studies (NIS) that use real-world data (RWD) for regulatory purposes. In the draft reflection paper, EMA defines a NIS as...